Skip to main content
Livermore
Livermore
ZHEN

Concorde Asset Management, LLC

SEC CIK
0001631773
Latest filing
Aug 18, 2026

The latest 13F from Concorde Asset Management, LLC covers Q2 2026 (filed Aug 18, 2026): 152 long positions worth $172.8M. The top 10 holdings make up 43.1% of the portfolio, and the largest is iShares Core S&P 500 ETF at 9.8%. Livermore has 21 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
24
Est. +$8.16M
Added
66
Est. +$8.78M
Reduced
57
Est. −$5.54M
Sold out
79
Est. −$67.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Core S&P 500 ETF464287200
    9.8%$16.9M
  2. Invesco Exch Traded FD Tr II46138E339
    5.6%$9.65M
  3. Invesco QQQ Trust Series I46090E103
    4.8%$8.33M
  4. SPYSPDR S&P 500 ETF Trust
    3.9%$6.72MHistory
  5. First Tr Exchange Traded FD33738R704
    3.7%$6.32M

Biggest buys

New and added positions, by estimated amount bought

  1. iShares Core S&P 500 ETF464287200
    +$1.30MAdded
  2. APHAmphenol Corp
    +$1.28MNewHistory
  3. First Tr Exchange-Traded FD33736G106
    +$1.21MAdded
  4. Invesco Exch Traded FD Tr II46138E339
    +$1.05MAdded
  5. First Tr Exchange Traded FD33738R704
    +$936.7KAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Core S&P 500 ETF464287200
    +3.11 pp6.7% → 9.8%
  2. Invesco Exch Traded FD Tr II46138E339
    +2.66 pp2.9% → 5.6%
  3. First Tr Exchange Traded FD33738R704
    +1.46 pp2.2% → 3.7%
  4. First Tr Exchange Traded FD33738R118
    +1.29 pp2.2% → 3.5%
  5. SPYSPDR S&P 500 ETF Trust
    +1.08 pp2.8% → 3.9%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. First Tr Exchng Traded FD VI33740F755
    −$5.09MSold out
  2. iShares Tr46434V613
    −$4.74MSold out
  3. First Tr Exchng Traded FD VI33740U752
    −$4.45MSold out
  4. First Tr Exchange-Traded FD33738D309
    −$3.28MSold out
  5. iShares Tr464288885
    −$3.07MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. First Tr Exchng Traded FD VI33740F755
    −2.49 pp2.5% → 0.0%
  2. iShares Tr46434V613
    −2.32 pp2.3% → 0.0%
  3. First Tr Exchng Traded FD VI33740U752
    −2.18 pp2.2% → 0.0%
  4. First Tr Exchange-Traded FD33738D309
    −1.61 pp1.6% → 0.0%
  5. iShares Tr464288885
    −1.51 pp1.5% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$172.8M
−$31.1M (−15.3%) vs. prior quarter
Positions
152
−55 vs. prior quarter
Top 10 concentration
43.1%
Top 10 as share of value
Turnover
9.0%
Q2 2026, one quarter
Average holding period
3.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

21 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $250.0M (Q4 2025)

Q1 2021: $173.4MQ2 2021: $178.1MQ3 2021: $173.3MQ4 2021: $163.3MQ1 2022: $150.5MQ2 2022: $66.3MQ3 2022: $89.3MQ4 2022: $112.3MQ1 2023: $84.3MQ2 2023: $108.4MQ3 2023: $111.1MQ4 2023: $146.0MQ1 2024: $145.8MQ2 2024: $162.2MQ3 2024: $177.2MQ4 2024: $191.8MQ1 2025: $185.8MQ3 2025: $239.1MQ4 2025: $250.0MQ1 2026: $204.0MQ2 2026: $172.8M
Q1 2021Q2 2026
13F filings of Concorde Asset Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 18, 2026152$172.8MiShares Core S&P 500 ETFInvesco Exch Traded FD Tr IIInvesco QQQ Trust Series Ivs. Q1 2026SEC
Q1 2026Jun 1, 2026207$204.0MiShares Core S&P 500 ETFInvesco QQQ Trust Series IInvesco Exch Traded FD Tr IIvs. Q4 2025SEC
Q4 2025Feb 13, 2026241$250.0MiShares Core S&P 500 ETFInvesco Exch Traded FD Tr IIInvesco QQQ Trust Series Ivs. Q3 2025SEC
Q3 2025Nov 14, 2025222$239.1MiShares Core S&P 500 ETFInvesco Exch Traded FD Tr IIInvesco QQQ Trust Series I–SEC
Q1 2025May 15, 2025175$185.8MFirst Tr Exchange-Traded FDiShares Core S&P 500 ETFiShares Trvs. Q4 2024SEC
Q4 2024Feb 13, 2025182$191.8MiShares Core S&P 500 ETFFirst Tr Exchange Traded FDInvesco QQQ Trust Series Ivs. Q3 2024SEC
Q3 2024Nov 12, 2024175$177.2MiShares Core S&P 500 ETFFirst Tr Exchng Traded FD VIFirst Tr Exchange Traded FDvs. Q2 2024SEC
Q2 2024Aug 12, 2024162$162.2MFirst Tr Exchng Traded FD VIiShares Core S&P 500 ETFInvesco QQQ Trust Series Ivs. Q1 2024SEC
Q1 2024May 15, 2024135$145.8MFirst Tr Exchng Traded FD VIiShares Core S&P 500 ETFFirst Tr Exchange Traded FDvs. Q4 2023SEC
Q4 2023Feb 15, 2024161$146.0MFirst Tr Exchng Traded FD VIiShares Core S&P 500 ETFSPYvs. Q3 2023SEC
Q3 2023Nov 13, 2023141$111.1MiShares Core S&P 500 ETFFirst Tr Exchng Traded FD VIFirst Trust Rising Dividend Achievers ETFvs. Q2 2023SEC
Q2 2023Jul 25, 2023128$108.4MiShares Core S&P 500 ETFFirst Tr Exchng Traded FD VIFirst Trust Rising Dividend Achievers ETFvs. Q1 2023SEC
Q1 2023May 9, 202379$84.3MiShares Core S&P 500 ETFFirst Tr Exchange-Traded FDiShares U.S. Medical Devices ETFvs. Q4 2022SEC
Q4 2022Feb 2, 2023143$112.3MiShares Core S&P 500 ETFFirst Tr Exchange-Traded FDMOvs. Q3 2022SEC
Q3 2022Oct 31, 2022139$89.3MiShares Core S&P 500 ETFiShares TrFirst Tr Exchange-Traded FDvs. Q2 2022SEC
Q2 2022Aug 5, 2022107$66.3MiShares Core S&P 500 ETFiShares TriShares Trvs. Q1 2022SEC
Q1 2022Apr 22, 2022152$150.5MiShares Core S&P 500 ETFiShares TrMOvs. Q4 2021SEC
Q4 2021Feb 2, 2022168$163.3MiShares Core S&P 500 ETFiShares TriShares Trvs. Q3 2021SEC
Q3 2021Oct 21, 2021194$173.3MiShares Core S&P 500 ETFiShares TriShares Trvs. Q2 2021SEC
Q2 2021Jul 20, 2021194$178.1MiShares Core S&P 500 ETFiShares TriShares U.S. Treasury Bond ETFvs. Q1 2021SEC
Q1 2021Apr 27, 2021210$173.4MiShares Core S&P 500 ETFiShares TriShares U.S. Treasury Bond ETF–SEC